Formation of 4,5,6,7-Tetrahydroisoindoles
(JC-F ) 23.0 Hz), 65.9, 59.1 (JC-F ) 2.4 Hz), 58.5, 52.7, 28.8;
HRMS (FAB) calcd for [M + H]+ (C17H19FNO) 272.1451, found
272.1452.
(br, 1H), 7.76 (d, J ) 8.6 Hz, 1H), 7.90-8.00 (m, 2H); 13C NMR
(CDCl3, 50 MHz) δ 168.8, 168.2, 167.9, 158.6, 143.6, 133.6, 129.4,
126.7, 124.5, 123.7, 120.8, 114.4, 113.9, 65.5, 35.6, 28.3, 24.7;
HRMS (FAB) calcd for [M + H]+ (C19H19N2O4) 339.1345, found
339.1343.
4,5,6,7-Tetrachloro-2-(3-phenoxypropyl)-2,3-dihydro-1H-isoin-
dole (8e). The procedure to prepare 8b was followed. Starting with
7e (0.50 g, 1.2 mmol) and LAH (0.14 g, 3.6 mmol), 8e (0.15 g,
0.39 mmol, 33%) was isolated after column chromatography (SiO2;
Ethyl-[2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-4-yl]-
amine (11f). The procedure to prepare 8b was followed. Starting
with 10f (0.43 g, 1.26 mmol) and LAH (0.14 g, 3.79 mmol), 11f
(0.29 g, 0.99 mmol, 78%) was produced after column chromatog-
1
hexanes/ethyl acetate, 3:1; Rf 0.67). H NMR (CDCl3, 200 MHz)
δ 2.04 (m, 2H), 2.91 (t, J ) 7.1 Hz, 2H), 3.95-4.15 (m, 6H), 6.80-
7.00 (m, 3H), 7.20-7.35 (m, 2H); 13C NMR (CDCl3, 50 MHz) δ
158.9, 139.2, 130.9, 129.4, 126.6, 120.7, 114.5, 65.4, 59.7, 52.2,
28.6; HRMS (FAB) calcd for [M + H]+ (C17H16Cl4NO) 389.9986,
found 389.9978.
1
raphy (SiO2; ethyl acetate; Rf 0.47). H NMR (CDCl3, 200 MHz)
δ 1.21 (t, J ) 6.9 Hz, 3H), 2.02 (m, 2H), 2.86 (t, J ) 7.0 Hz, 2H),
3.13 (q, J ) 7.1 Hz, 2H), 3.15 (br, 1H, NH), 3.75 (s, 2H), 3.91 (s,
2H), 4.04 (t, J ) 6.4 Hz, 2H), 6.43 (d, J ) 8.0 Hz, 1H), 6.56 (d,
J ) 7.3 Hz, 1H), 6.80-6.97 (m, 3H), 7.00-7.13 (m, 1H), 7.18-
7.33 (m, 2H); 13C NMR (CDCl3, 50 MHz) δ 159.0, 143.1, 140.6,
129.4, 128.3, 124.2, 120.5, 114.5, 111.2, 108.5, 65.9, 59.8, 56.6,
52.8, 38.4, 28.8, 15.0; HRMS (FAB) calcd for [M + H]+
(C19H25N2O) 297.1967, found 297.1968.
4-Methoxy-2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindole (8h).
The procedure to prepare 8b was followed. Starting with 7h (0.18
g, 0.59 mmol) and LAH (0.07 g, 1.8 mmol), 8h (0.11 g, 0.40 mmol,
67%) was isolated after column chromatography (SiO2; hexanes/
1
ethyl acetate, 3:1; Rf 0.50). H NMR (CDCl3, 500 MHz) δ 2.05
(m, 2H), 2.90 (t, J ) 7.0 Hz, 2H), 3.80 (s, 3H), 3.94 (s, 2H), 3.96
(s, 2H), 4.08 (t, J ) 6.4 Hz, 2H), 6.69 (d, J ) 8.2 Hz, 1H), 6.80
(d, J ) 3.8 Hz, 1H), 6.88-6.95 (m, 3H), 7.14-7.20 (m, 1H), 7.22-
7.30 (m, 2H); 13C NMR (CDCl3, 125 MHz) δ 159.1, 154.6, 142.0,
129.4, 128.3, 127.7, 120.6, 114.7, 114.6, 108.6, 66.0, 59.6, 56.4,
55.3, 52.8, 28.8; HRMS (FAB) calcd for [M + H]+ (C18H22NO2)
284.1651, found 284.1649.
N-Ethyl,N-[2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-5-
yl]amine (11g). The procedure to prepare 8b was followed. Starting
with 10g (0.05 g, 0.13 mmol) and LAH (0.02 g, 0.40 mmol), 11g
(0.04 g, 0.12 mmol, 94%) was isolated after column chromatog-
raphy (SiO2; hexanes/ethyl acetate, 1:1; Rf 0.27). 1H NMR (CDCl3,
200 MHz) δ 1.23 (t, J ) 7.0 Hz, 3H), 2.04 (m, 2H), 2.89 (t, J )
7.2 Hz, 2H), 3.13 (q, J ) 7.2 Hz, 2H), 3.14 (br, NH), 3.86 (s, 2H),
3.88 (s, 2H), 4.08 (t, J ) 6.4 Hz, 2H), 6.46 (m, 2H), 6.85-7.03
(m, 4H), 7.20-7.35 (m, 2H); 13C NMR (CDCl3, 50 MHz) δ 159.0,
147.8, 141.2, 129.4, 128.7, 122.7, 120.5, 114.5, 111.8, 106.7, 66.0,
59.4, 58.7, 52.9, 38.8, 28.8, 14.9; HRMS (FAB) calcd for [M +
H]+ (C19H25N2O) 297.1967, found 297.1967.
N-Ethyl,N-[2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-4-
yl]acetamide (12f). The procedure to prepare 10f was followed.
Starting with 11f (0.23 g, 0.78 mmol) and acetyl chloride (0.12 g,
1.6 mmol), 12f (0.21 g, 0.63 mmol, 81%) was produced. 1H NMR
(CDCl3, 200 MHz) δ 1.10 (t, J ) 7.1 Hz, 3H), 1.80 (s, 3H), 2.05
(m, 2H), 2.92 (m, 2H), 3.29-3.50 (m, 1H), 3.80-4.15 (m, 7H),
6.75-7.00 (m, 4H), 7.08-7.35 (m, 4H); 13C NMR (CDCl3, 50
MHz) δ 169.8, 158.8, 142.5, 138.1, 137.2, 129.3, 128.3, 126.8,
122.1, 120.6, 114.4, 65.6, 59.3, 57.3, 52.6, 42.7, 28.6, 22.4, 13.1;
HRMS (FAB) calcd for [M + H]+ (C21H27N2O2) 339.2073, found
339.2079.
N-Ethyl,N-[2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-5-
yl]acetamide (12g). The procedure to prepare 10f was followed.
Starting with 11g (0.19 g, 0.65 mmol) and acetyl chloride (0.10 g,
1.3 mmol), 12f (0.21 g, 0.61 mmol, 94%) was produced. 1H NMR
(CDCl3, 200 MHz) δ 1.07 (t, J ) 7.1 Hz, 3H), 1.79 (s, 3H), 2.06
(m, 2H), 2.93 (m, 2H), 3.70 (q, J ) 7.1 Hz, 2H), 3.96 (s, 4H), 4.08
(t, J ) 6.3 Hz, 2H), 6.75-7.05 (m, 5H), 7.15-7.36 (m, 3H); 13C
NMR (CDCl3, 50 MHz) δ 170.0, 158.9, 141.8, 141.7, 139.8, 129.4,
126.8, 123.3, 122.1, 120.6, 114.5, 65.8, 58.9, 58.7, 52.6, 43.8, 28.7,
22.8, 13.0; HRMS (FAB) calcd for [M + H]+ (C21H27N2O2)
339.2073, found 339.2079.
4-Amino-2-(3-phenoxypropyl)-isoindole-1,3-dione (9f). Pal-
ladium on carbon (5%, 85 mg) was added to the solution of 7f
(0.13 g, 0.39 mmol) in methanol (4 mL) and DMF (1 mL).
Hydrogen gas was bubbled through the reaction mixture at rt for
14 h. The solution was filtered and concentrated. The crude product
was further purified by column chromatography (SiO2; ethyl acetate/
hexanes, 1:1; Rf 0.75) to give pure 9f as a light yellow solid (0.11
g, 0.37 mmol, 94%). Mp 77-79 °C; 1H NMR (CDCl3, 200 MHz)
δ 2.13 (m, 2H), 3.82 (t, J ) 6.8 Hz, 2H), 3.99 (t, J ) 6.1 Hz, 2H),
5.23 (br, 2H), 6.68-6.98 (m, 4H), 7.05-7.42 (m, 4H); 13C NMR
(CDCl3, 50 MHz) δ 170.1, 168.6, 158.6, 145.2, 135.0, 132.7, 129.3,
120.9, 120.6, 114.4, 112.5, 111.2, 65.4, 34.9, 28.4; HRMS (FAB)
calcd for [M + H]+ (C17H17N2O3) 297.1239, found 297.1240.1
5-Amino-2-(3-phenoxypropyl)isoindole-1,3-dione (9g). The
procedure to prepare 9f was followed. Starting with 7g (0.38 g,
1.2 mmol), 9g (0.34 g, 1.13 mmol, 97%) was isolated after column
chromatography (SiO2; ethyl acetate; Rf 0.77). Mp 107-110 °C;
1H NMR (CDCl3, 200 MHz) δ 2.15 (m, 2H), 3.84 (t, J ) 7.0 Hz,
2H), 4.01 (t, J ) 6.2 Hz, 2H), 4.36 (br, 2H), 6.67-7.07 (m, 5H),
7.12-7.32 (m, 2H), 7.58 (d, J ) 8.0 Hz, 1H); 13C NMR (CDCl3,
50 MHz) δ 168.6, 168.5, 158.7, 152.2, 134.9, 129.3, 125.0, 120.7,
120.6, 117.8, 114.5, 108.5, 65.5, 35.1, 28.5; HRMS (FAB) calcd
for [M + H]+ (C17H17N2O3) 297.1239, found 297.1242.
N-[1,3-Dioxo-2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-
4-yl]acetamide (10f). Acetyl chloride (0.16 g, 2.1 mmol) in
acetonitrile (5 mL) was added to the mixture of 9f (0.51 g, 1.7
mmol) and potassium carbonate (0.60 g, 4.3 mmol) in acetonitrile
(7 mL). The reaction mixture was stirred at rt for 16 h, filtered,
concentrated, and purified by flash column chromatography (SiO2;
hexanes/ethyl acetate, 1:1; Rf 0.50) to give pure 10f (0.43 g, 1.3
N,N-Diethyl,N-[2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-
4-yl]amine (13f). The procedure to prepare 8b was followed.
Starting with 12f (0.15 g, 0.42 mmol) and LAH (0.02 g, 0.42 mmol),
13f (0.68 g, 0.21 mmol, 50%) was isolated after column chroma-
tography (SiO2; hexanes/ethyl acetate, 1:1 and Et3N, 2%; Rf 0.62).
1H NMR (CDCl3, 200 MHz) δ 1.04 (t, J ) 7.0 Hz, 3H), 2.09 (m,
2H), 2.92 (m, 2H), 3.11 (q, J ) 7.0 Hz, 4H), 3.94 (s, 4H), 4.10 (t,
J ) 6.4 Hz, 2H), 6.75-7.00 (m, 5H), 7.09-7.36 (m, 3H); 13C NMR
(CDCl3, 50 MHz) δ 159.0, 145.8, 141.6, 132.7, 129.3, 127.3, 120.5,
117.4, 115.1, 114.5, 66.0, 59.5, 58.8, 52.8, 45.9, 28.8, 12.6; HRMS
(FAB) calcd for [M + H]+ (C21H29N2O) 325.2280, found 325.2274.1
N,N-Diethyl,N-[2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-
5-yl]amine (13g). The procedure to prepare 8b was followed.
Starting with 12g (0.11 g, 0.34 mmol) and LAH (0.01 g, 0.34
mmol), 13g (0.03 g, 0.09 mmol, 26%) was isolated after column
chromatography (SiO2; hexanes/ethyl acetate, 1:1 and Et3N, 2%;
1
mmol, 74%) as a light yellow solid. Mp 115-118 °C; H NMR
(CDCl3, 200 MHz) δ 2.15 (m, 2H), 2.22 (s, 3H), 3.86 (t, J ) 6.8
Hz, 2H), 4.01 (t, J ) 5.8 Hz, 2H), 6.63-6.97 (m, 3H), 7.10-7.30
(m, 2H), 7.40-7.70 (m, 2H), 8.73 (d, J ) 8.4 Hz, 1H), 9.45 (br,
1H); 13C NMR (CDCl3, 50 MHz) δ 170.2, 169.2, 167.8, 158.6,
137.3, 135.8, 131.6, 129.4, 124.6, 120.8, 117.9, 115.7, 114.4, 65.5,
35.6, 28.2, 24.9; HRMS (FAB) calcd for [M + H]+ (C19H19N2O4)
339.1345, found 339.1349.
N-[1,3-Dioxo-2-(3-phenoxypropyl)-2,3-dihydro-1H-isoindol-
5-yl]acetamide (10g). The procedure to prepare 10f was followed.
Starting with 9g (0.19 g, 0.65 mmol), 10g (0.21 g, 0.61 mmol,
93%) was produced as a light yellow solid. 1H NMR (CDCl3, 200
MHz) δ 2.12 (m, 2H), 2.24 (s, 3H), 3.87 (t, J ) 7.0 Hz, 2H), 4.00
(t, J ) 6.0 Hz, 2H), 6.72-6.95 (m, 3H), 7.15-7.30 (m, 2H), 7.63
1
Rf 0.43). H NMR (CDCl3, 200 MHz) δ 1.13 (t, J ) 7.0 Hz, 3H),
J. Org. Chem, Vol. 72, No. 24, 2007 9237